Like the increased use of electronic medical records throughout the health-care industry, office-based primary-care physicians are implementing the systems in their practices, too. Indeed, a Medical Economics (1/21/05) survey of nearly 2,000 family and general practitioners, internists, ob/gyns, and pediatricians found that 15% use EMRs. Among ob/gyns alone, 12% say they use EMRs.
Like the increased use of electronic medical records throughout the health-care industry, office-based primary-care physicians are implementing the systems in their practices, too. Indeed, a Medical Economics (1/21/05) survey of nearly 2,000 family and general practitioners, internists, ob/gyns, and pediatricians found that 15% use EMRs. Among ob/gyns alone, 12% say they use EMRs.
The survey found that most EMR users are young (47% are under the age of 44), in a large practice (65% are in practices with 11 or more physicians), and a generalist (42% are family or general practitioners or internists). In addition, 23% of all respondents-and 19% of ob/gyns alone-plan to purchase an EMR system in the next 12 months.
Of the ob/gyns who said they already use EMR systems, 66% said they were "very satisfied" or "satisfied" with them. Nearly half of ob/gyns with EMR systems said that the system's templates were "very close" or "close" to their own practice styles, while 52% said customizing templates required "a lot of work." Still, about two thirds of ob/gyns (65%) said they expect a return on their investment.
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More